Wells Fargo & Company Rx Sight, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Rx Sight, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 48,055 shares of RXST stock, worth $2.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,055
Previous 35,917
33.79%
Holding current value
$2.54 Million
Previous $1.85 Million
56.1%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RXST
# of Institutions
233Shares Held
31.4MCall Options Held
57.8KPut Options Held
12.5K-
Ra Capital Management, L.P. Boston, MA3.69MShares$196 Million3.35% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$127 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$106 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.74MShares$91.9 Million0.35% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.33MShares$70.6 Million0.13% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.46B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...